SLI
2.011,71
PKT
+0,56
PKT
+0,03
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 27.01.20 | UBS Hold | Deutsche Bank AG | |
| 27.01.20 | Givaudan Hold | Deutsche Bank AG | |
| 27.01.20 | Roche buy | Deutsche Bank AG | |
| 24.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 24.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 24.01.20 | Givaudan buy | UBS AG | |
| 24.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Givaudan add | Baader Bank | |
| 24.01.20 | Givaudan Underperform | Bernstein Research | |
| 24.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 24.01.20 | Swiss Re overweight | Barclays Capital | |
| 24.01.20 | Nestlé Hold | Jefferies & Company Inc. | |
| 23.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 23.01.20 | UBS buy | Kepler Cheuvreux | |
| 23.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.01.20 | UBS Outperform | Credit Suisse Group | |
| 22.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 22.01.20 | Swiss Re Outperform | Credit Suisse Group | |
| 22.01.20 | Holcim Neutral | UBS AG | |
| 22.01.20 | Roche buy | Jefferies & Company Inc. | |
| 22.01.20 | Swiss Re Hold | Jefferies & Company Inc. | |
| 22.01.20 | UBS overweight | JP Morgan Chase & Co. | |
| 22.01.20 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.20 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 21.01.20 | Roche buy | Merrill Lynch & Co., Inc. | |
| 21.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 21.01.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 21.01.20 | UBS overweight | Morgan Stanley | |
| 21.01.20 | UBS Underweight | Barclays Capital | |
| 21.01.20 | UBS Hold | Deutsche Bank AG | |
| 21.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 21.01.20 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.01.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Holcim overweight | Barclays Capital | |
| 20.01.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.20 | UBS Equal weight | Barclays Capital |